Hemispherx biopharma, inc.

关于 Hemispherx biopharma, inc.

评论 12
3.9
联系我们

关于公司

AIM ImmunoTech is engaged in the clinical development of new drug entities for the treatment of seriously debilitating disorders.

US
未知
未知
未验证公司